文献速递类风湿关节炎

西班牙风湿病学会/西班牙肺病与胸外科协会间质性肺病筛查标准在早期类风湿关节炎患者中的验证研究

Validation study of the SER/SEPAR screening criteria for interstitial lung disease in early rheumatoid arthritis patients.
PubMed 文献 · Semin Arthritis Rheum · 2025-04-30

本横断面研究回顾性评估西班牙风湿病学会(SER)与西班牙肺病与胸外科协会(SEPAR)2023年提出的类风湿关节炎(RA)间质性肺病(ILD)筛查标准在146例早期RA患者中的灵敏度与特异度。结果显示标准灵敏度92.9%、特异度45.8%,作者认为其高灵敏度支持作为早期检测工具。

要点

  • 146例早期RA患者中28例(19.2%)经高分辨率CT确诊ILD。
  • SER/SEPAR标准灵敏度92.9%、特异度45.8%、阴性预测值96.4%。
  • 61.6%患者符合筛查标准,其中28.9%确诊ILD。

核心结论

  • SER/SEPAR标准在近期起病的RA患者中显示出高灵敏度,作者认为支持其作为该情境下早期检测的工具。

研究设计与样本

  • 横断面研究,回顾性评估SER/SEPAR筛查标准在146例诊断时接受ILD筛查的早期RA患者中的表现。

主要发现

  • 146例患者中28例(19.2%)发生ILD且均经胸部高分辨率CT确诊,其中12例(43%)ILD在关节症状之前或同时出现,其余16例(57%)在应用筛查方案后发现。
  • 诊断时90例(61.6%)符合筛查标准,其中26例(28.9%)确诊ILD;56例(38.4%)不符合标准者中最终2例(3.5%)发现ILD。
  • SER/SEPAR筛查标准灵敏度92.9%(95%CI:76.5-99.1),特异度45.8%(95%CI:36.6-55.2),阳性似然比1.71(95%CI:1.41-2.08),阴性似然比0.16(95%CI:0.04-0.60),阳性预测值28.9%(95%CI:25.1-33.1),阴性预测值96.4%(95%CI:87.5-99.1),诊断准确率54.8%(95%CI:46.4-63.1)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In 2023, the Spanish Society of Rheumatology (SER) and the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) proposed screening criteria for interstitial lung disease (ILD) in rheumatoid arthritis (RA) based on expert opinion, requiring validation. This study aimed to evaluate their sensitivity and specificity in a cohort of early RA patients. METHODS: This cross-sectional study retrospectively assessed the SER/SEPAR criteria in 146 early RA patients screened for ILD at diagnosis. Screening included medical history, respiratory auscultation, chest X-ray (CXR), and complete pulmonary function tests (PFTs). Thoracic high-resolution computed tomography (HRCT) was performed only in the presence of symptoms, velcro crackles, or abnormalities on CXR or PFTs. RESULTS: Among the 146 patients included, 28 (19.2 %) developed ILD, all confirmed by HRCT. Of these, 12 (43 %) had clinically evident ILD preceding or coinciding with joint symptoms, while the remaining 16 (57 %) were identified after applying the screening protocol. At diagnosis, 90 patients (61.6 %) met the screening criteria, with ILD confirmed in 26 cases (28.9 %). Conversely, among 56 patients (38.4 %) not meeting the criteria, ILD was ultimately identified in 2 cases (3.5 %). The SER/SEPAR screening criteria demonstrated a sensitivity of 92.9 % (95 % CI: 76.5-99.1), specificity of 45.8 % (95 % CI: 36.6-55.2), LR+ of 1.71 (95 % CI: 1.41-2.08), LR- of 0.16 (95 % CI: 0.04-0.60), PPV of 28.9 % (95 % CI: 25.1-33.1), NPV of 96.4 % (95 % CI: 87.5-99.1), and diagnostic accuracy of 54.8 % (95 % CI: 46.4-63.1). CONCLUSION: The SER/SEPAR criteria for ILD screening demonstrated high sensitivity in recent-onset RA patients, supporting their utility as a tool for early detection in this scenario.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Aguilar-Coll M, Narváez J. Validation study of the SER/SEPAR screening criteria for interstitial lung disease in early rheumatoid arthritis patients. Semin Arthritis Rheum. 2025. PMID: 40334368. doi:10.1016/j.semarthrit.2025.152738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。